Determination of Fragmentation Schemes and Metabolites of Fluorinated Histone Deacetylase Inhibitors for Use as Positron Emission Tomography Imaging Agents Using HPLC-MS/MS

Histone Deacetylase ◽

Histone Deacetylase Inhibitors ◽

Emission Tomography ◽

Imaging Agents ◽

Tomography Imaging ◽

Design, Synthesis, and Evaluation of (2-Aminocyclopropyl)phenyl Derivatives as Novel Positron Emission Tomography Imaging Agents for Lysine-Specific Demethylase 1 in the Brain

Journal of Medicinal Chemistry ◽

10.1021/acs.jmedchem.0c01937 ◽

2021 ◽

Vol 64 (7) ◽

pp. 3780-3793

Author(s):

Yasushi Hattori ◽

Satoru Matsuda ◽

Rina Baba ◽

Kouta Matsumiya ◽

Shinji Iwasaki ◽

...

Keyword(s):

Emission Tomography ◽

Imaging Agents ◽

Design Synthesis ◽

Tomography Imaging ◽

Lysine Specific Demethylase ◽

Positron Emission ◽

The Brain

Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s002590050480 ◽

1999 ◽

Vol 26 (11) ◽

pp. 1465-1574 ◽

Cited By ~ 39

Author(s):

Gerold Porenta ◽

Simon Cherry ◽

Johannes Czernin ◽

Richard Brunken ◽

William Kuhle ◽

...

Keyword(s):

Blood Flow ◽

Oxygen Consumption ◽

Myocardial Blood Flow ◽

Emission Tomography ◽

Tomography Imaging ◽

Positron Emission ◽

Normal Humans

Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation

Coordination Chemistry Reviews ◽

10.1016/j.ccr.2017.05.011 ◽

2017 ◽

Vol 352 ◽

pp. 499-516 ◽

Cited By ~ 17

Author(s):

Lachlan E. McInnes ◽

Stacey E. Rudd ◽

Paul S. Donnelly

Keyword(s):

Metal Ion ◽

Emission Tomography ◽

Imaging Agents ◽

Tomography Imaging ◽

Positron Emission ◽

Metal Ion Speciation

Determination of Synthetic Impurities and Metabolic Products of F-ADAM, a Positron Emission Tomography Imaging Agent for Serotonin Transporter (SERT) Using HPLC-Tandem Mass Spectrometry

Pharmacology &amp Pharmacy ◽

10.4236/pp.2020.1110023 ◽

2020 ◽

Vol 11 (10) ◽

pp. 282-298

Author(s):

Wei-Hsi Chen ◽

Chyng-Yann Shiue

Keyword(s):

Mass Spectrometry ◽

Tandem Mass Spectrometry ◽

Emission Tomography ◽

Tandem Mass ◽

Tomography Imaging ◽

Positron Emission ◽

Metabolic Products

Synthesis and Evaluation of18F-Labeled 2-Phenylbenzothiazoles as Positron Emission Tomography Imaging Agents for Amyloid Plaques in Alzheimer’s Disease

Journal of Medicinal Chemistry ◽

10.1021/jm8013376 ◽

2009 ◽

Vol 52 (5) ◽

pp. 1428-1437 ◽

Cited By ~ 57

Author(s):

Kim Serdons ◽

Christelle Terwinghe ◽

Peter Vermaelen ◽

Koen Van Laere ◽

Hank Kung ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Amyloid Plaques ◽

Emission Tomography ◽

Imaging Agents ◽

Tomography Imaging ◽

Synthesis and Evaluation of a Novel Series of 2-Chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine Analogues as Potential Positron Emission Tomography Imaging Agents for Nicotinic Acetylcholine Receptors

Journal of Medicinal Chemistry ◽

10.1021/jm010550n ◽

2002 ◽

Vol 45 (13) ◽

pp. 2841-2849 ◽

Cited By ~ 18

Author(s):

LaVerne L. Brown ◽

Santosh Kulkarni ◽

Olga A. Pavlova ◽

Andrei O. Koren ◽

Alexey G. Mukhin ◽

...

Keyword(s):

Nicotinic Acetylcholine Receptors ◽

Acetylcholine Receptors ◽

Emission Tomography ◽

Imaging Agents ◽

Nicotinic Acetylcholine ◽

Tomography Imaging ◽

Positron Emission ◽

Vinyl Pyridine

ChemInform Abstract: Synthesis and Biological Activity of Fluoro-Substituted Pyrrolo[2,3-d]pyrimidines. The Development of Potential Positron Emission Tomography Imaging Agents for the Corticotropin-Releasing Hormone Type 1 Receptor.

ChemInform ◽

10.1002/chin.200029121 ◽

2010 ◽

Vol 31 (29) ◽

pp. no-no

Author(s):

Ling-Wei Hsin ◽

Elizabeth L. Webster ◽

George P. Chrousos ◽

Philip W. Gold ◽

William C. Eckelman ◽

...

Keyword(s):

Biological Activity ◽

Emission Tomography ◽

Imaging Agents ◽

Corticotropin Releasing Hormone ◽

Releasing Hormone ◽

Tomography Imaging ◽

Synthesis and biological activity of fluoro-substituted pyrrolo[2,3- d ]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/s0960-894x(00)00071-8 ◽

2000 ◽

Vol 10 (8) ◽

pp. 707-710 ◽

Cited By ~ 18

Author(s):

Ling-Wei Hsin ◽

Elizabeth L Webster ◽

George P Chrousos ◽

Philip W Gold ◽

William C Eckelman ◽

...

Keyword(s):

Biological Activity ◽

Emission Tomography ◽

Imaging Agents ◽

Corticotropin Releasing Hormone ◽

Releasing Hormone ◽

Tomography Imaging ◽

Positron emission tomography imaging agents for evaluating the pathologic features of Alzheimer's disease and drug development

Neurotherapeutics in the Era of Translational Medicine ◽

10.1016/b978-0-12-816475-4.00013-6 ◽

2021 ◽

pp. 367-412

Author(s):

Yiyun Henry Huang ◽

Hongmei Jia ◽

Weiqi Bao

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Drug Development ◽

Emission Tomography ◽

Imaging Agents ◽

Tomography Imaging ◽

Positron Emission ◽

Pathologic Features

Synthesis of 10-fluoroalkyl-dihydrotetrabenazines as potential positron emission tomography-imaging agents for vesicular monoamine transporter type II

Drug and Alcohol Dependence ◽

10.1016/j.drugalcdep.2014.02.271 ◽

2014 ◽

Vol 140 ◽

pp. e93

Author(s):

Ling-Wei Hsin ◽

J. Katz ◽

T. Kopajtic ◽

C. Yang ◽

Y. Chen

Keyword(s):

Emission Tomography ◽

Imaging Agents ◽

Vesicular Monoamine Transporter ◽

Type Ii ◽

Monoamine Transporter ◽

Tomography Imaging ◽